Criminal Code Regulations 2002

Part 1—Preliminary

1 Name of Regulations

These Regulations are the Criminal Code Regulations 2002.

2 Commencement

These Regulations commence on gazettal.

3 Definition

In these Regulations:

Code means the Criminal Code.

Part 2—Security of the Commonwealth

4 Preventative detention orders—corresponding State preventative detention law

(1) For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, a law of a State or Territory that is set out in Part 1 of Schedule 1 is declared to correspond to Division 105 of the Code.

(2) For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, particular provisions of a law of a State or Territory that are set out in Part 2 of Schedule 1 are declared to correspond to Division 105 of the Code.

4H Terrorist organisations—Ansar al‑Islam

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Ansar al‑Islam is specified.

(2) For subregulation (1), Ansar al‑Islam is also known by the following names:

(a) Ansar al‑Islam Army;

(b) Ansar al‑Sunna;

(d) Devotees of Islam;

(e) Followers of Islam in Kurdistan;

(f) Jaish Ansar al‑Islam;

(g) Jaish Ansar al‑Sunna;

(h) Jund al‑Islam;

(i) Kurdish Taliban;

(j) Kurdistan Supporters of Islam;

(k) Partisans of Islam;

(l) Protectors of Islam;

(m) Protectors of the Sunni Faith;

(n) Soldiers of God;

(o) Soldiers of Islam;

(p) Supporters of Islam in Kurdistan.

4J Terrorist organisations—Islamic Movement of Uzbekistan

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Islamic Movement of Uzbekistan is specified.

(2) For subregulation (1), Islamic Movement of Uzbekistan is also known by the following names:

(a) IMU;

(b) Islamic Movement of Turkestan;

4K Terrorist organisations—Jaish‑e‑Mohammad (JeM)

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Jaish‑e‑Mohammad (JeM) is specified.

(2) For subregulation (1), Jaish‑e‑Mohammad (JeM) is also known by the following names:

(a) Army of Mohammed;

(b) Army of the Prophet;

(d) Jaish‑e‑Muhammed;

(e) Jaish‑i‑Mohammed;

(f) Jaish‑i‑Mohammad;

(g) Jaish‑i‑Muhammad;

(h) Jaish‑i‑Muhammed;

(i) Jaish‑e‑Mohammad Mujahideen E‑Tanzeem;

(j) Jamaat ul‑Furqan (JuF);

(k) Jeish‑e‑Mahammed;

(l) Jesh‑e‑Mohammadi;

(m) Khudamul Islam;

(n) Khuddam ul‑Islam (KuI);

(o) Kuddam e Islami;

(p) Mohammed’s Army;

(q) National Movement for the Restoration of Pakistani Sovereignty and Army of the Prophet;

(r) Tehrik Ul‑Furqaan.

4L Terrorist organisations—Lashkar‑e Jhangvi (LeJ)

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Lashkar‑e Jhangvi (LeJ) is specified.

(2) For subregulation (1), Lashkar‑e Jhangvi (LeJ) is also known by the following names:

(a) Jhangvi Army;

(b) Lashkar e Jhangvi;

(d) Lashkar Jhangvi;

(e) Lashkar‑e‑Jhangvie;

(f) Lashkar‑e‑Jhangwi;

(g) Lashkar‑e‑Jhanvi;

(h) Lashkar‑i‑Jangvi;

(i) Lashkar‑i‑Jhangvi;

(j) Lashkar‑i‑Jhangwi;

(k) Lashkare Jhangvi;

(l) Laskar e Jahangvi;

(m) Laskar‑e‑Jhangvi.

4Q Terrorist organisations—Hizballah’s External Security Organisation

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Hizballah’s External Security Organisation is specified.

(2) For subregulation (1), Hizballah’s External Security Organisation is also known by the following names:

(a) Foreign Action Unit;

(b) Hizballah ESO;

(d) Islamic Jihad Organisation;

(e) Revolutionary Justice Organisation;

(f) Special Operations Branch.

4T Terrorist organisations—Palestinian Islamic Jihad

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Palestinian Islamic Jihad is specified.

(2) For subregulation (1), Palestinian Islamic Jihad is also known by the following names:

(a) al‑Quds Brigades;

(b) Harakat al‑Jihad al‑Islami fi Filistin;

(d) Islamic Jihad Palestine;

(e) Islamic Jihad—Palestine Faction and Islamic Holy War;

(f) PIJ.

4U Terrorist organisations—Hamas’ Izz al‑Din al‑Qassam Brigades

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Hamas’ Izz al‑Din al‑Qassam Brigades is specified.

(2) For subregulation (1), Hamas’ Izz al‑Din al‑Qassam Brigades is also known by the following names:

(a) Ezzedeen Al‑Qassam Brigades;

(b) Izz al‑Din Al‑Qassem Brigades.

4V Terrorist organisations—Lashkar‑e‑Tayyiba

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Lashkar‑e‑Tayyiba is specified.

(2) For subregulation (1), Lashkar‑e‑Tayyiba is also known by the following names:

(a) al Mansooreen;

(b) al Mansoorian;

(d) Army of the Pure;

(e) Army of the Pure and Righteous;

(f) Army of the Righteous;

(g) Falah‑e‑Insaniyat Foundation;

(h) Idara Khidmat‑e‑Khalq;

(i) Jama’at al‑Dawa;

(j) Jama’at‑i‑Dawat;

(k) Jamaati‑ud‑Dawa;

(l) Jamaat ud‑Daawa;

(m) Jama’at‑ud‑Da’awa;

(n) Jama’at‑ud‑Da’awah;

(o) Jamaat‑ud‑Dawa;

(p) Jama’at ul‑Da’awa;

(q) Jamaat‑ul‑Dawa;

(r) Jamaat ul‑Dawah;

(s) Jamaiat‑ud‑Dawa;

(t) JuD;

(u) JUD;

(v) Lashkar‑e‑Taiba;

(w) Lashkar‑e‑Tayyaba;

(x) Lashkar‑e‑Toiba;

(y) Lashkar‑i‑Tayyaba;

(z) Lashkar‑i‑Toiba;

(za) Lashkar‑Tayyiba;

(zb) LeT;

(zc) LT;

(zd) Paasban‑e‑Ahle‑Hadis;

(ze) Paasban‑e‑Kashmir;

(zf) Paasban‑i‑Ahle‑Hadith;

(zg) Party of the Calling;

(zh) Party of Preachers;

(zi) Pasban‑e‑Ahle‑Hadith;

(zj) Pasban‑e‑Kashmir;

(zk) Soldiers of the Pure;

(zl) Tehreek‑e‑Tahafuz Qibla Awal.

4W Terrorist organisations—Kurdistan Workers Party (PKK)

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Kurdistan Workers Party is specified.

(2) For subregulation (1), Kurdistan Workers Party is also known by the following names:

(a) Freedom and Democratic Congress of Kurdistan;

(b) Hezan Parastina Gel (HPG);

(d) KG;

(e) KHK;

(f) Kongra Gel;

(g) Kongra Gele Kurdistan;

(h) Kurdish Freedom Falcons;

(i) Kurdish Liberation Hawks;

(j) Kurdistan Freedom and Democracy Congress;

(k) Kurdistan Freedom Brigade;

(l) Kurdistan Freedom Hawks;

(m) Kurdistan Halk Kongresi;

(n) Kurdistan Labor Party;

(o) Kurdistan Ozgurluk Sahinleri;

(p) Kurdistan People’s Congress;

(q) New PKK;

(r) Partiya Karkeren Kurdistan;

(s) People’s Congress of Kurdistan;

(t) People’s Defence Force;

(u) PKK;

(v) TAK;

(w) Teyrbazên Azadiya Kurdistan.

4X Terrorist organisations—Al‑Shabaab

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Al‑Shabaab is specified.

(2) For subregulation (1), Al‑Shabaab is also known by the following names:

(a) Al‑Shabaab Al‑Islaam;

(b) Al‑Shabaab al‑Islamiya;

(d) Al‑Shabab;

(e) Ash‑shabaab;

(f) Harakat al‑Shabaab al‑Mujahideen;

(g) Harakat Shabab Al‑Mujahidin;

(h) Harakatul Shabaab al‑Mujaahidiin;

(i) Hisb’ul Shabaab;

(j) Hizbul Shabaab;

(k) HSM;

(l) Mujaahidiin Youth Movement;

(m) Mujahideen Youth Movement;

(n) Mujahidin Al‑Shabaab Movement;

(o) Mujahidin Youth Movement;

(p) MYM;

(q) Shabaab;

(r) The Popular Resistance Movement in the Land of the Two Migrations;

(s) The Unity of Islamic Youth;

(t) The Youth;

(u) Young Mujahideen Movement;

(v) Young Mujahideen Movement in Somalia, Youth Wing.

4Y Terrorist organisations—Al‑Qa’ida in the Arabian Peninsula (AQAP)

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Al‑Qa’ida in the Arabian Peninsula (AQAP) is specified.

(2) For subregulation (1), Al‑Qa’ida in the Arabian Peninsula (AQAP) is also known as Al‑Qa’ida in Yemen (AQY).

Part 3—Dangers to the community

Division 3.1—Cross‑border firearms trafficking

5 Cross‑border firearms trafficking

For the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the Acts, and any regulations made under those Acts, mentioned in Schedule 2 are prescribed.

Division 3.2—Serious drugs and precursors

5A Controlled drugs

(1) For paragraph 301.1(1)(a) of the Code, a drug listed in column 1 of an item in Schedule 3 is a controlled drug.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 3 is the commercial quantity of the controlled drug listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 3 is the marketable quantity of the controlled drug listed in column 1 of that item.

(4) For paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity listed in column 4 of an item in Schedule 3 is the trafficable quantity of the controlled drug listed in column 1 of that item.

5B Controlled plants

(1) For paragraph 301.2(1)(a) of the Code, a growing plant listed in column 1 of an item in the following table is a controlled plant.

Controlled plants and quantities
Item	Column 1	Column 2	Column 3	Column 4
	Controlled plant	Commercial quantity	Marketable quantity	Trafficable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants	250 g or 10 plants

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the controlled plant listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the controlled plant listed in column 1 of that item.

(4) For paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity listed in column 4 of an item in the table in subregulation (1) is the trafficable quantity of the controlled plant listed in column 1 of that item.

5C Controlled precursors

(1) For paragraph 301.3(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a controlled precursor.

Controlled precursors and quantities
Item	Column 1	Column 2	Column 3
	Controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Ephedrine	1.2	400.0
2	Ergometrine	0.006	0.15
3	Ergotamine	0.01	0.25
4	Isosafrole	1.45	290.0
5	Lysergic acid	0.003	0.075
6	3,4‑Methylenedioxyphenylacetic acid	1.5	300.0
7	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	150.0
8	Phenylacetic acid	4.05	1,350.0
9	Phenylpropanolamine	1.2	400.0
10	Phenyl‑2‑propanone	2.03	675.0
11	Piperonal	1.6	320.0
12	Pseudoephedrine	1.2	400.0
13	Safrole	2.85	570.0

Note: A salt or ester of a precursor listed in column 1 of the table is also a controlled precursor: see paragraph 301.3(b) of the Code.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the controlled precursor listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the controlled precursor listed in column 1 of that item.

5D Border controlled drugs

(1) For paragraph 301.4(a) of the Code, a drug listed in column 1 of an item in Schedule 4 is a border controlled drug.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 4 is the commercial quantity of the border controlled drug listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 4 is the marketable quantity of the border controlled drug listed in column 1 of that item.

5E Border controlled plants

(1) For paragraph 301.5(a) of the Code, a growing plant listed in column 1 of an item in the following table is a border controlled plant.

Border controlled plants and quantities
Item	Column 1	Column 2	Column 3
	Border controlled plant	Commercial quantity	Marketable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants
2	Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation		80 kg
3	Any plant of the genus Lophophora
4	Any plant of the species Papaver bracteatum		10 kg
5	Any plant of the species Papaver somniferum		10 kg
6	Any plant of the species Piptagenia peregrine
7	Any plant of the species Psilocybe

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the border controlled plant listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the border controlled plant listed in column 1 of that item.

5F Border controlled precursors

(1) For paragraph 301.6(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a border controlled precursor.

Border controlled precursors and quantities
Item	Column 1	Column 2	Column 3
	Border controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	N‑Acetylanthranilic acid
2	Any plant of the species Ephedra
3	Ephedrine	1.2	3.2
4	Ergometrine	0.006	0.006
5	Ergotamine	0.01	0.01
6	Isosafrole	1.45	1.45
7	Lysergic acid	0.003	0.003
8	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	0.75
9	Phenylacetic acid	4.05	10.8
10	Phenylpropanolamine	1.2	3.2
11	Phenyl‑2‑propanone	2.03	5.4
12	Piperonal	1.6	1.6
13	Pseudoephedrine	1.2	3.2
14	Safrole	2.85	2.85

Note: A salt or ester of a precursor listed in column 1 of the table and an immediate precursor of a precursor listed in column 1 of the table is a border controlled precursor: see paragraphs 301.6(1)(b) and (c) of the Code.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the border controlled precursor listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the border controlled precursor listed in column 1 of that item.

Part 4—National infrastructure

6 Dangerous goods

For subparagraph 471.15(1)(b)(ii) of the Code, the following substances and things must not, without exception, be carried by post:

(a) gas that is so toxic or corrosive to humans as to pose a hazard to health;

(b) a thermally unstable substance that is likely to undergo a strongly exothermic decomposition;

Schedule 1—Corresponding State preventative detention law

(regulation 4)

Part 1—Laws of a State or Territory

Item	Declared laws
1	Terrorism (Preventative Detention) Act 2005 (Qld)
1A	Terrorism (Preventative Detention) Act 2006 (WA)
2	Terrorism (Preventative Detention) Act 2005 (SA)
3	Terrorism (Preventative Detention) Act 2005 (Tas)

Part 2—Particular provisions of a law of a State or Territory

Item	Declared provisions
1	Part 2A, Terrorism (Police Powers) Act 2002 (NSW)
2	Part 2A, Terrorism (Community Protection) Act 2003 (Vic)
3	Part 2, Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT)
4	Part 2B, Terrorism (Emergency Powers) Act (NT)

Schedule 2—Cross‑border firearms trafficking

(regulation 5)

Item	Act
1	Firearms Act 1996 (NSW)
2	Firearms Act 1996 (Vic)
3	Weapons Act 1990 (Qld)
4	Firearms Act 1973 (WA)
5	Firearms Act 1977 (SA)
6	Firearms Act 1996 (Tas)
7	Firearms Act 1996 (ACT)
8	Firearms Act 1997 (NT)
9	Firearms Act 1997 (Norfolk Island)

Schedule 3—Controlled drugs

Note: See regulation 5A.

Controlled drugs and quantities
Item	Column 1	Column 2	Column 3	Column 4
	Controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)	Trafficable quantity (grams)
1	Acetorphine	2.0	250.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	2.5	0.005
3	4‑Acetoxy‑N, N‑dimethyltryptamine (4‑AcO‑DMT)	2.0	250.0	2.0
4	4‑Acetoxy‑N‑methyl‑N‑ethyltryptamine (4‑AcO‑MET)	2.0	250.0	2.0
5	Acetylcodeine	2.0	250.0	2.0
6	Acetyldihydrocodeine	2.0	250.0	2.0
7	Acetylmethadol	2.0	250.0	2.0
8	Allylprodine	2.0	250.0	2.0
9	Alphacetylmethadol	10.0	5,000.0	10.0
10	Alphameprodine	0.2	100.0	0.2
11	Alphamethadol	0.2	100.0	0.2
12	alpha‑Methylfentanyl	0.005	2.5	0.005
13	alpha‑Methylthiofentanyl	0.005	2.5	0.005
14	alpha‑Pyrrolidinobutiophenone (α‑PBP)	0.75	250.0	0.75
15	alpha‑Pyrrolidinopropiophenone (α‑PPP)	0.75	250.0	0.75
16	alpha‑Pyrrolidinovalerophenone (α‑PVP)	0.75	250.0	0.75
17	Alphaprodine	25.0	12,500.0	25.0
18	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	250.0	0.75
19	6‑(2‑Aminopropyl)‑2,3‑dihydrobenzofuran (6‑APDB)	0.75	250.0	0.75
20	Amphetamine	0.75	250.0	0.75
21	Anileridine	25.0	12,500.0	25.0
22	Barbiturates	5.0		5.0
23	Benzethidine	10.0	5,000.0	10.0
24	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	250.0	0.75
25	Benzoylecgonine	2.0	250.0	2.0
26	Benzylmorphine	5.0	2,500.0	5.0
27	Benzylpiperazine	0.75	250.0	0.75
28	Betacetylmethadol	5.0	2,500.0	5.0
29	beta‑Hydroxyfentanyl	0.005	2.5	0.005
30	beta‑Hydroxy‑3‑methylfentanyl	0.005	2.5	0.005
31	beta‑Keto‑methylbenzodioxolylpentanamine (pentylone)	0.75	250.0	0.75
32	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	250.0	0.75
33	Betameprodine	5.0	2,500.0	5.0
34	Betamethadol	5.0	2,500.0	5.0
35	Betaprodine	5.0	2,500.0	5.0
36	Bezitramide	5.0	2,500.0	5.0
37	2‑Bromoamphetamine	0.75	250.0	0.75
38	3‑Bromoamphetamine	0.75	250.0	0.75
39	4‑Bromoamphetamine	0.75	250.0	0.75
40	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	100.0	0.5
41	2‑Bromo‑5‑methoxymethcathinone	0.75	250.0	0.75
42	2‑Bromomethamphetamine	0.75	250.0	0.75
43	3‑Bromomethamphetamine	0.75	250.0	0.75
44	4‑Bromomethamphetamine	0.75	250.0	0.75
45	2‑Bromomethcathinone	0.75	250.0	0.75
46	3‑Bromomethcathinone	0.75	250.0	0.75
47	4‑Bromomethcathinone	0.75	250.0	0.75
48	Bufotenine	2.0	250.0	2.0
49	Bupropion	0.75	250.0	0.75
50	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	125.0	25,000.0	125.0
51	Cannabis resin	125.0	25,000.0	125.0
52	Cathinone	0.75	250.0	0.75
53	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	100.0	0.5
54	2‑Chloroamphetamine	0.75	250.0	0.75
55	3‑Chloroamphetamine	0.75	250.0	0.75
56	4‑Chloroamphetamine	0.75	250.0	0.75
57	2‑Chloromethamphetamine	0.75	250.0	0.75
58	3‑Chloromethamphetamine	0.75	250.0	0.75
59	4‑Chloromethamphetamine	0.75	250.0	0.75
60	4‑Chloro‑N‑ethylamphetamine	0.75	250.0	0.75
61	2‑Chloromethcathinone	0.75	250.0	0.75
62	3‑Chloromethcathinone	0.75	250.0	0.75
63	4‑Chloromethcathinone	0.75	250.0	0.75
64	4‑Chlorophenyl‑1‑methoxypropan‑2‑amine	0.75	250.0	0.75
65	Chlorphentermine	2.0	250.0	2.0
66	Clonitazene	5.0	100.0	5.0
67	Cocaine	2.0	250.0	2.0
68	Codeine	10.0	5,000.0	10.0
69	Codeine‑N‑oxide	10.0	5,000.0	10.0
70	Codoxime	10.0	5,000.0	10.0
71	Desomorphine	2.0	250.0	2.0
72	Dexamphetamine	2.0	250.0	2.0
73	Dextromoramide	2.0	250.0	2.0
74	Diampromide	5.0	2,500.0	5.0
75	Diethylpropion (N, N‑Diethylcathinone)	5.0	2,500.0	5.0
76	Diethylthiambutene	5.0	2,500.0	5.0
77	N,N‑Diethyltryptamine	2.0	250.0	2.0
78	Difenoxin	2.0	250.0	2.0
79	1‑(2,3‑Dihydro‑1‑benzofuran‑5‑yl)propan‑2‑amine (5‑APDB)	0.75	250.0	0.75
80	Dihydrocodeine	10.0	5,000.0	10.0
81	Dihydromorphine	10.0	5,000.0	10.0
82	Dimenoxadol	10.0	5,000.0	10.0
83	Dimepheptanol	10.0	5,000.0	10.0
84	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	100.0	0.5
85	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	100.0	0.5
86	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	100.0	0.5
87	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	250	0.75
88	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	100.0	0.5
89	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	100.0	0.5
90	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	100.0	0.5
91	3,4‑Dimethoxymethcathinone	0.75	250.0	0.75
92	1‑Dimethylamino‑1,2‑diphenylethane	5.0	2,500.0	5.0
93	N,N‑Dimethylamphetamine	0.75	250.0	0.75
94	N, N‑Dimethylcathinone	0.75	250.0	0.75
95	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	1,000.0	5.0
96	3,4‑Dimethylmethcathinone	0.75	250.0	0.75
97	Dimethylthiambutene	20.0	10,000.0	20.0
98	N,N‑Dimethyltryptamine	2.0	250.0	2.0
99	Dioxaphetyl butyrate	2.0	250.0	2.0
100	Diphenoxylate	2.0	250.0	2.0
101	Dipipanone	10.0	5,000.0	10.0
102	Drotebanol	2.0	250.0	2.0
103	Ecgonine	10.0	5,000.0	10.0
104	Ethchlorvynol	50.0		50.0
105	Ethinamate	50.0		50.0
106	N‑Ethylcathinone	0.75	250.0	0.75
107	Ethylmethylthiambutene	10.0	5,000.0	10.0
108	Ethylmorphine	2.0	250.0	2.0
109	3‑(2‑Ethylphenyl)‑2‑methyl‑quinazolin‑4‑one (Etaqualone)	5.0		5.0
110	Etonitazene	5.0	2,500.0	5.0
111	Etorphine	5.0	2,500.0	5.0
112	Etoxeridine	5.0	2,500.0	5.0
113	Fentanyl	0.005	2.5	0.005
114	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	100.0	0.5
115	2‑Fluoroamphetamine	0.75	250.0	0.75
116	3‑Fluoroamphetamine	0.75	250.0	0.75
117	4‑Fluoroamphetamine	0.75	250.0	0.75
118	2‑Fluoromethamphetamine	0.75	250.0	0.75
119	3‑Fluoromethamphetamine	0.75	250.0	0.75
120	4‑Fluoromethamphetamine	0.75	250.0	0.75
121	2‑Fluoromethcathinone	0.75	250.0	0.75
122	3‑Fluoromethcathinone	0.75	250.0	0.75
123	4‑Fluoromethcathinone	0.75	250.0	0.75
124	Furethidine	1.0	500.0	1.0
125	Gammabutyrolactone (GBL)	1.0	250.0	1.0
126	Glutethimide	50.0		50.0
127	Heroin (diacetylmorphine)	1.5	250.0	1.5
128	Hydrocodone	2.0	250.0	2.0
129	Hydromorphinol	2.0	250.0	2.0
130	Hydromorphone	2.0	250.0	2.0
131	Hydroxyamphetamine	2.0	250.0	2.0
132	4‑Hydroxybutanoic acid (GHB)	1.0	250.0	1.0
133	p‑Hydroxyephedrine	2.0	250.0	2.0
134	Hydroxypethidine	0.75	250.0	0.75
135	2‑Iodoamphetamine	0.75	250.0	0.75
136	3‑Iodoamphetamine	0.75	250.0	0.75
137	4‑Iodoamphetamine	0.75	250.0	0.75
138	2‑Iodomethamphetamine	0.75	250.0	0.75
139	3‑Iodomethamphetamine	0.75	250.0	0.75
140	4‑Iodomethamphetamine	0.75	250.0	0.75
141	2‑Iodomethcathinone	0.75	250.0	0.75
142	3‑Iodomethcathinone	0.75	250.0	0.75
143	4‑Iodomethcathinone	0.75	250.0	0.75
144	Isomethadone	2.0	250.0	2.0
145	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	100.0	0.5
146	Ketamine	1.0	500.0	1.0
147	Ketobemidone	2.0	250.0	2.0
148	Levophenacylmorphan	2.0	250.0	2.0
149	Levomethorphan	2.0	250.0	2.0
150	Levorphanol, but not including dextrorphan	1.0	500.0	1.0
151	Lysergamides	0.01		0.01
152	Lysergide (LSD)	0.002	0.05	0.002
153	Meprobamate	50.0		50.0
154	Mescaline	7.5	3.75	7.5
155	Metazocine	7.0	3,500.0	7.0
156	Methadone	2.0	250.0	2.0
157	Methamphetamine	0.75	250.0	0.75
158	Methaqualone	5.0		5.0
159	Methcathinone	0.75	250.0	0.75
160	Methorphan, but not including dextromethorphan	2.0	250.0	2.0
161	4’‑Methoxy‑alpha‑pyrrolidinopropiophenone (MOPPP)	0.75	250.0	0.75
162	4‑Methoxyamphetamine	0.75	250.0	0.75
163	4‑Methoxymethamphetamine	0.75	250.0	0.75
164	4‑Methoxymethcathinone	0.75	250.0	0.75
165	4’‑Methyl‑alpha‑pyrrolidinobutiophenone (MPBP)	0.75	250.0	0.75
166	4’‑Methyl‑alpha‑pyrrolidinohexiophenone (MPHP)	0.75	250.0	0.75
167	4’‑Methyl‑alpha‑pyrrolidinopropiophenone (MPPP)	0.75	250.0	0.75
168	N‑Methyl butylone	0.75	250.0	0.75
169	2‑Methylamino‑1‑phenylbutan‑1‑ one (buphedrone)	0.75	250.0	0.75
170	4‑Methylamphetamine	0.75	250.0	0.75
171	3,4‑Methylenedioxyamphetamine (MDA)	0.75	100.0	0.75
172	4‑Methylethcathinone	0.75	250.0	0.75
173	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	100.0	0.5
174	Methyldesorphine	2.0	250.0	2.0
175	Methyldihydromorphine	2.0	250.0	2.0
176	3,4‑Methylenedioxyethcathinone (MDEC)	0.75	250.0	0.75
177	3,4‑Methylenedioxymethcathinone (MDMC)	0.75	250.0	0.75
178	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	250.0	0.75
179	3’,4’‑Methylenedioxy‑alpha‑pyrrolidinobutiophenone (MDPBP)	0.75	250.0	0.75
180	3’,4’‑Methylenedioxy‑alpha‑pyrrolidinopropiophenone (MDPPP)	0.75	250.0	0.75
181	3‑Methylfentanyl	0.005	2.5	0.005
182	4‑Methylmethamphetamine	0.75	250.0	0.75
183	4‑Methylmethcathinone (4‑MMC)	0.75	250.0	0.75
184	Methylphenidate	2.0	250.0	2.0
185	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	250.0	2.0
186	4‑Methylthioamphetamine (4‑MTA)	0.75	250.0	0.75
187	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	250.0	0.75
188	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	250.0	0.75
189	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	250.0	0.75
190	3‑Methylthiofentanyl	0.005	2.5	0.005
191	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	250.0	0.75
192	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	250.0	0.75
193	Methyprylon	50.0		50.0
194	Metopon	2.0	250.0	2.0
195	Monoacetylmorphines	2.0	250.0	2.0
196	Moramide	2.0	250.0	2.0
197	Morphan, but not including dextrorphan	2.0	250.0	2.0
198	Morpheridine	2.0	250.0	2.0
199	Morphine	1.5	250.0	1.5
200	Morphine‑N‑oxide	2.0	250.0	2.0
201	Myrophine	20.0		20.0
202	Nicocodine	2.0	250.0	2.0
203	Nicodicodine	2.0	250.0	2.0
204	Nicomorphine	2.0	250.0	2.0
205	Noracymethadol	2.0	250.0	2.0
206	Norcodeine	2.0	250.0	2.0
207	Norlevorphanol	2.0	250.0	2.0
208	Normethadone	5.0	2,500.0	5.0
209	Normorphine	20.0		20.0
210	Norpipanone	10.0	5,000.0	10.0
211	Opium	20.0	10,000.0	20.0
212	Oripavine	2.0	250.0	2.0
213	Oxycodone	5.0	2,500.0	5.0
214	Oxymorphone	2.0	250.0	2.0
215	para‑Fluorofentanyl	0.005	2.5	0.005
216	Pentazocine	20.0		20.0
217	Pethidine	10.0	5,000.0	10.0
218	Phenadoxone	10.0	5,000.0	10.0
219	Phenampromide	10.0	5,000.0	10.0
220	Phenazocine	1.0	500.0	1.0
221	Phencyclidine	2.0	250.0	2.0
222	Phendimetrazine	5.0	2,500.0	5.0
223	Phenmetrazine	5.0	2,500.0	5.0
224	Phenomorphan	5.0	2,500.0	5.0
225	Phenoperidine	1.0	500.0	1.0
226	Phentermine	5.0	2,500.0	5.0
227	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	250.0	2.0
228	Pholcodine	5.0	2,500.0	5.0
229	Piminodine	10.0	5,000.0	10.0
230	Pipradrol	1.0	500.0	1.0
231	Piritramide	1.0	500.0	1.0
232	Proheptazine	1.0	500.0	1.0
233	Properidine	25.0	12,500.0	25.0
234	Propiram	10.0	5,000.0	10.0
235	Psilocine	2.0	1,000.0	2.0
236	Psilocybine	2.0	1,000.0	2.0
237	Pyrovalerone	0.75	250.0	0.75
238	Tetrahydrocannabinols (THC)	5.0	1,000.0	5.0
239	Thebacon	2.0	250.0	2.0
240	Thebaine	2.0	250.0	2.0
241	Thiofentanyl	0.005	2.5	0.005
242	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	100.0	0.5
243	Trimeperidine	10.0	5,000.0	10.0
244	2,3,4‑Trimethoxyamphetamine	0.75	250.0	0.75
245	2,3,5‑Trimethoxyamphetamine	0.75	250.0	0.75
246	2,3,6‑Trimethoxyamphetamine	0.75	250.0	0.75
247	2,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75
248	2,4,6‑Trimethoxyamphetamine	0.75	250.0	0.75
249	3,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75

Note: A drug analogue of a drug listed in column 1 of the table is a controlled drug: see paragraph 301.1(b) of the Code.

Schedule 4—Border controlled drugs

Note: See regulation 5D.

Border controlled drugs and quantities
Item	Column 1	Column 2	Column 3
	Border controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Acetorphine	2.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	0.005
3	Acetylcodeine	2.0	2.0
4	Acetyldihydrocodeine	2.0	2.0
5	Acetylmethadol	2.0	2.0
6	Allylprodine	2.0	2.0
7	Alphacetylmethadol	10.0	10.0
8	Alphameprodine	0.2	0.2
9	Alphamethadol	0.2	0.2
10	alpha‑Methylfentanyl	0.005	0.005
11	alpha‑Methylthiofentanyl	0.005	0.005
12	Alphaprodine	25.0	25.0
13	Amphecloral	2.0	2.0
14	3‑(2‑Aminopropyl)indole (alpha‑methyltryptamine (AMT))	2.0	2.0
15	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	0.5
16	Amphetamine	0.75	2.0
17	Anileridine	25.0	25.0
18	Barbiturates	5.0	50.0
19	Benzethidine	10.0	10.0
20	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	0.5
21	Benzoylecgonine	2.0	2.0
22	Benzylmorphine	5.0	5.0
23	Benzylpiperazine	0.75	2.0
24	Betacetylmethadol	5.0	5.0
25	beta‑Hydroxyfentanyl	0.005	0.005
26	beta‑Hydroxy‑3‑methylfentanyl	0.005	0.005
27	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	2.0
28	Betameprodine	5.0	5.0
29	Betamethadol	5.0	5.0
30	Betaprodine	5.0	5.0
31	Bezitramide	5.0	5.0
32	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	0.5
33	Bufotenine	2.0	2.0
34	Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)	2.0	2.0
35	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	100.0	25,000.0
36	Cannabis resin	50.0	20.0
37	Cathinone	0.75	2.0
38	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	0.5
39	Chlorphentermine	2.0	2.0
40	Clonitazene	5.0	5.0
41	Cocaine	2.0	2.0
42	Codeine	10.0	10.0
43	Codeine‑N‑oxide	10.0	10.0
44	Codoxime	10.0	10.0
45	Desomorphine	2.0	2.0
46	Dexamphetamine	2.0	2.0
47	Dextromoramide	2.0	2.0
48	Diampromide	5.0	5.0
49	Diethylpropion (N, N‑Diethylcathinone)	5.0	5.0
50	Diethylthiambutene	5.0	5.0
51	N,N‑Diethyltryptamine	2.0	2.0
52	Difenoxin	2.0	2.0
53	Dihydrocodeine	10.0	10.0
54	Dihydromorphine	10.0	10.0
55	Dimenoxadol	10.0	10.0
56	Dimepheptanol	10.0	10.0
57	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	0.5
58	2,5‑Dimethoxy‑4‑(n)‑butylthiophenethylamine (2C‑T‑9)	0.5	0.5
59	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	0.5
60	2,5‑Dimethoxy‑4‑ethylthiophenethylamine (2C‑T‑2)	0.5	0.5
61	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	0.5
62	2,5‑Dimethoxy‑4‑(β‑isobutylthio)phenethylamine (2C‑T‑17)	0.5	0.5
63	2,5‑Dimethoxy‑4‑isopropylthiophenethylamine (2C‑T‑4)	0.5	0.5
64	2,5‑Dimethoxy‑4‑(β‑methoxyethylthio)phenethylamine (2C‑T‑13)	0.5	0.5
65	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	2.0
66	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	0.5
67	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	0.5
68	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	0.5
69	2,5‑Dimethoxy‑4‑n‑propylthiophenethylamine (2C‑T‑7)	0.5	0.5
70	1‑Dimethylamino‑1,2‑diphenylethane	5.0	5.0
71	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	2.0
72	Dimethylthiambutene	20.0	20.0
73	N,N‑Dimethyltryptamine	2.0	2.0
74	Dioxaphetyl butyrate	2.0	2.0
75	Diphenoxylate	2.0	2.0
76	Dipipanone	10.0	10.0
77	Drotebanol	2.0	2.0
78	Ecgonine	10.0	10.0
79	Ethchlorvynol	50.0	50.0
80	Ethinamate	50.0	50.0
81	Ethylmethylthiambutene	10.0	10.0
82	Ethylmorphine	2.0	2.0
83	Etonitazene	5.0	5.0
84	Etorphine	5.0	5.0
85	Etoxeridine	5.0	5.0
86	Fentanyl	0.005	0.005
87	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	0.5
88	4‑(2‑Fluoroethylthio)‑2,5‑dimethoxyphenethylamine (2C‑T‑21)	0.5	0.5
89	1‑(5‑fluoropentyl)‑3‑(2‑iodobenzyl)indole (AM‑694)	5.0	2.0
90	Furethidine	1.0	1.0
91	Gammabutyrolactone (GBL)	1.0	2.0
92	Glutethimide	50.0	50.0
93	Harmaline	5.0	2.0
94	Harmine	5.0	2.0
95	Heroin (diacetylmorphine)	1.5	2.0
96	Hydrocodone	2.0	2.0
97	Hydromorphinol	2.0	2.0
98	Hydromorphone	2.0	2.0
99	Hydroxyamphetamine	2.0	2.0
100	4‑Hydroxybutanoic acid (GHB)	1.0	2.0
101	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methyloctan‑2‑yl)phenol (CP 47,497)	5.0	2.0
102	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methylnonan‑2‑yl)phenol (CP 47,497‑C8)	5.0	2.0
103	Hydroxypethidine	5.0	5.0
104	Isomethadone	2.0	2.0
105	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	0.5
106	Ketamine	1.0	3.0
107	Ketobemidone	2.0	2.0
108	Levophenacylmorphan	2.0	2.0
109	Levomethorphan	2.0	2.0
110	Levorphanol, but not including dextrorphan	1.0	1.0
111	Lysergamide	0.01	0.1
112	Lysergide (LSD)	0.002	0.002
113	Meprobamate	50.0	50.0
114	Mescaline	7.5	7.5
115	Metazocine	7.0	7.0
116	Methadone	2.0	2.0
117	Methamphetamine	0.75	2.0
118	Methaqualone	5.0	50.0
119	Methcathinone	0.75	2.0
120	Methorphan, but not including dextromethorphan	2.0	2.0
121	5‑Methoxy‑alpha‑methyltryptamine (5‑MeO‑AMT)	2.0	2.0
122	5‑Methoxy‑N,N‑diisopropyltryptamine (5‑MeO‑DiPT)	2.0	2.0
123	4‑Methoxyamphetamine	0.75	2.0
124	4‑Methoxymethamphetamine	0.75	2.0
125	4‑Methylamphetamine	0.75	2.0
126	3,4‑Methylenedioxyamphetamine (MDA)	0.75	0.5
127	2‑(2‑Methoxyphenyl)‑1‑(1‑pentylindol‑3‑yl)ethanone (JWH‑250)	5.0	2.0
128	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	0.5
129	Methyldesorphine	2.0	2.0
130	Methyldihydromorphine	2.0	2.0
131	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	2.0
132	3‑Methylfentanyl	0.005	0.005
133	4‑Methylmethamphetamine	0.75	2.0
134	4‑Methylmethcathinone (4‑MMC)	0.75	2.0
135	Methylphenidate	2.0	2.0
136	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	2.0
137	4‑Methylthio‑2,5‑dimethoxyphenethylamine (2C‑T)	0.5	0.5
138	4‑Methylthioamphetamine (4‑MTA)	0.75	2.0
139	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	2.0
140	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	2.0
141	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	2.0
142	3‑Methylthiofentanyl	0.005	0.005
143	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	2.0
144	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	2.0
145	Methyprylon	50.0	50.0
146	Metopon	2.0	2.0
147	Monoacetylmorphines	2.0	2.0
148	Moramide	2.0	2.0
149	Morphan, but not including dextrorphan	2.0	2.0
150	Morpheridine	2.0	2.0
151	Morphine	1.5	2.0
152	Morphine‑N‑oxide	2.0	2.0
153	(1‑(2‑Morpholin‑4‑ylethyl)indol‑3‑yl)‑napthalen‑1‑ylmethanone (JWH‑200)	5.0	2.0
154	Myrophine	20.0	20.0
155	Napthalen‑1‑yl‑(1‑butylindol‑3‑yl)methanone (JWH‑073)	5.0	2.0
156	Nicocodine	2.0	2.0
157	Nicodicodine	2.0	2.0
158	Nicomorphine	2.0	2.0
159	Noracymethadol	2.0	2.0
160	Norcodeine	2.0	2.0
161	Norlevorphanol	2.0	2.0
162	Normethadone	5.0	5.0
163	Normorphine	20.0	20.0
164	Norpipanone	10.0	10.0
165	Opium	20.0	20.0
166	Oripavine	2.0	2.0
167	Oxycodone	5.0	5.0
168	Oxymorphone	2.0	2.0
169	para‑Fluorofentanyl	0.005	0.005
170	Pentazocine	20.0	20.0
171	1‑Pentyl‑3‑(1‑napthoyl)indol (JWH‑018)	5.0	2.0
172	Pethidine	10.0	10.0
173	1‑Pentyl‑3‑(4‑methyl‑1‑napthoyl)indole (JWH‑122)	5.0	2.0
174	Phenadoxone	10.0	10.0
175	Phenampromide	10.0	10.0
176	Phenazocine	1.0	1.0
177	Phencyclidine	2.0	2.0
178	Phendimetrazine	5.0	5.0
179	Phenmetrazine	5.0	5.0
180	Phenomorphan	5.0	5.0
181	Phenoperidine	1.0	1.0
182	Phentermine	5.0	5.0
183	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	2.0
184	Pholcodine	5.0	5.0
185	Piminodine	10.0	10.0
186	Pipradrol	1.0	1.0
187	Piritramide	1.0	1.0
188	Proheptazine	1.0	1.0
189	Properidine	25.0	25.0
190	Propiram	10.0	10.0
191	Psilocine	0.1	0.1
192	Psilocybine	0.1	0.1
193	Pyrovalerone	0.75	2.0
194	Tetrahydrocannabinols (THC)	5.0	2.0
195	Thebacon	2.0	2.0
196	Thebaine	2.0	2.0
197	Thiofentanyl	0.005	0.005
198	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	0.5
199	Trimeperidine	10.0	10.0
200	2,3,4‑Trimethoxyamphetamine	0.75	2.0
201	2,3,5‑Trimethoxyamphetamine	0.75	2.0
202	2,3,6‑Trimethoxyamphetamine	0.75	2.0
203	2,4,5‑Trimethoxyamphetamine	0.75	2.0
204	2,4,6‑Trimethoxyamphetamine	0.75	2.0
205	3,4,5‑Trimethoxyamphetamine	0.75	2.0

Note: A drug analogue of a drug listed in column 1 of the table is a border controlled drug: see paragraph 301.4(b) of the Code.

Endnotes

Endnote 1—Legislation history

This endnote sets out details of the legislation history of the Criminal Code Regulations 2002.

Number and year	Gazettal or FRLI registration date	Commencement date	Application, saving and transitional provisions
2002 No. 67	12 Apr 2002	12 Apr 2002
2002 No. 248	21 Oct 2002	21 Oct 2002	—
2002 No. 249	21 Oct 2002	21 Oct 2002 (a)	—
2002 No. 250	27 Oct 2002	27 Oct 2002	—
2002 No. 269	14 Nov 2002	14 Nov 2002	—
2002 No. 270	14 Nov 2002	14 Nov 2002	—
2002 No. 271	14 Nov 2002	14 Nov 2002	—
2002 No. 272	14 Nov 2002	14 Nov 2002	—
2003 No. 30	7 Mar 2003	7 Mar 2003	—
2003 No. 43	27 Mar 2003	27 Mar 2003	—
2003 No. 59	11 Apr 2003	11 April 2003	—
2003 No. 60	11 Apr 2003	11 April 2003	—
2003 No. 61	11 Apr 2003	11 April 2003	—
2003 No. 62	11 Apr 2003	11 April 2003	—
2003 No. 63	11 Apr 2003	11 April 2003	—
2003 No. 64	11 Apr 2003	11 April 2003	—
2003 No. 184	18 July 2003	5 June 2003	—
2003 No. 285	9 Nov 2003	9 Nov 2003	—
2004 No. 83	3 May 2004	3 May 2004	—
2004 No. 283	1 Sept 2004	1 Sept 2004	—
2004 No. 284	1 Sept 2004	1 Sept 2004	—
2004 No. 311	5 Nov 2004	5 Nov 2004	—
2004 No. 312	5 Nov 2004	5 Nov 2004	—
2004 No. 313	5 Nov 2004	5 Nov 2004	—
2004 No. 314	5 Nov 2004	5 Nov 2004	—
2005 No. 23	1 Mar 2005 (see F2005L00384)	2 Mar 2005	—
2005 No. 36	23 Mar 2005 (see F2005L00699)	27 Mar 2005	—
2005 No. 57	8 Apr 2005 (see F2005L00703)	11 Apr 2005	—
2005 No. 58	8 Apr 2005 (see F2005L00702)	11 Apr 2005	—
2005 No. 59	8 Apr 2005 (see F2005L00707)	11 Apr 2005	—
2005 No. 60	8 Apr 2005 (see F2005L00701)	11 Apr 2005	—
2005 No. 61	8 Apr 2005 (see F2005L00706)	11 Apr 2005	—
2005 No. 62	8 Apr 2005 (see F2005L00850)	11 Apr 2005	—
2005 No. 85	26 May 2005 (see F2005L01201)	5 June 2005	—
2005 No. 86	26 May 2005 (see F2005L01202)	5 June 2005	—
2005 No. 87	26 May 2005 (see F2005L01203)	5 June 2005	—
2005 No. 88	26 May 2005 (see F2005L01204)	5 June 2005	—
2005 No. 214	6 Oct 2005 (see F2005L02976)	7 Oct 2005	—
2005 No. 298	16 Dec 2005 (see F2005L04036)	17 Dec 2005	—
2006 No. 178	14 July 2006 (see F2006L01551)	15 July 2006	—
2006 No. 220	25 Aug 2006 (see F2006L02639)	26 Aug 2006	—
2006 No. 221	25 Aug 2006 (see F2006L02640)	26 Aug 2006	—
2006 No. 276	2 Nov 2006 (see F2006L03473)	3 Nov 2006	—
2006 No. 277	2 Nov 2006 (see F2006L03474)	3 Nov 2006	—
2006 No. 278	2 Nov 2006 (see F2006L03475)	3 Nov 2006	—
2006 No. 279	2 Nov 2006 (see F2006L03476)	3 Nov 2006	—
2006 No. 280	2 Nov 2006 (see F2006L03538)	3 Nov 2006	—
2007 No. 3	16 Feb 2007 (see F2007L00284)	17 Feb 2007	—
2007 No. 39	23 Mar 2007 (see F2007L00577)	24 Mar 2007	—
2007 No. 47	30 Mar 2007 (see F2007L00847)	31 Mar 2007	—
2007 No. 48	30 Mar 2007 (see F2007L00850)	31 Mar 2007	—
2007 No. 49	30 Mar 2007 (see F2007L00713)	31 Mar 2007	—
2007 No. 50	30 Mar 2007 (see F2007L00851)	31 Mar 2007	—
2007 No. 51	30 Mar 2007 (see F2007L00848)	31 Mar 2007	—
2007 No. 52	30 Mar 2007 (see F2007L00712)	31 Mar 2007	—
2007 No. 125	24 May 2007 (see F2007L01465)	25 May 2007	—
2007 No. 265	7 Sept 2007 (see F2007L03535)	8 Sept 2007	—
2007 No. 266	7 Sept 2007 (see F2007L03537)	8 Sept 2007	—
2007 No. 267	7 Sept 2007 (see F2007L03536)	8 Sept 2007	—
2007 No. 290	27 Sept 2007 (see F2007L03752)	28 Sept 2007	—
2008 No. 160	8 Aug 2008 (see F2008L02843)	9 Aug 2008	—
2008 No. 161	8 Aug 2008 (see F2008L02845)	9 Aug 2008	—
2008 No. 162	8 Aug 2008 (see F2008L02844)	9 Aug 2008	—
2008 No. 218	31 Oct 2008 (see F2008L03611)	1 Nov 2008	—
2008 No. 219	31 Oct 2008 (see F2008L03612)	1 Nov 2008	—
2008 No. 220	31 Oct 2008 (see F2008L03610)	1 Nov 2008	—
2009 No. 34	13 Mar 2009 (see F2009L00835)	14 Mar 2009	—
2009 No. 35	13 Mar 2009 (see F2009L00834)	14 Mar 2009	—
2009 No. 36	13 Mar 2009 (see F2009L00838)	14 Mar 2009	—
2009 No. 37	13 Mar 2009 (see F2009L00837)	14 Mar 2009	—
2009 No. 38	13 Mar 2009 (see F2009L00836)	14 Mar 2009	—
2009 No. 39	13 Mar 2009 (see F2009L00833)	14 Mar 2009	—
2009 No. 77	15 May 2009 (see F2009L01297)	16 May 2009	—
2009 No. 124	25 June 2009 (see F2009L02476)	(b)	—
2009 No. 125	25 June 2009 (see F2009L02471)	(b)	—
2009 No. 126	25 June 2009 (see F2009L02477)	(b)	—
2009 No. 127	25 June 2009 (see F2009L02478)	(b)	—
2009 No. 208	21 Aug 2009 (see F2009L03208)	22 Aug 2009	—
2009 No. 212	7 Sept 2009 (see F2009L03396)	8 Sept 2009	—
2009 No. 213	7 Sept 2009 (see F2009L03397)	8 Sept 2009	—
2009 No. 214	7 Sept 2009 (see F2009L03398)	8 Sept 2009	—
2009 No. 215	7 Sept 2009 (see F2009L03399)	8 Sept 2009	—
2010 No. 219	21 July 2010 (see F2010L02093)	22 July 2010	—
2010 No. 220	21 July 2010 (see F2010L02094)	22 July 2010	—
2010 No. 221	21 July 2010 (see F2010L02095)	22 July 2010	—
2010 No. 222	21 July 2010 (see F2010L02096)	(c)	—
2010 No. 252	28 Oct 2010 (see F2010L02825)	29 Oct 2010	—
2010 No. 253	28 Oct 2010 (see F2010L02826)	29 Oct 2010	—
2010 No. 254	28 Oct 2010 (see F2010L02828)	29 Oct 2010	—
2011 No. 45	8 Apr 2011 (see F2011L00586)	9 Apr 2011	—
2012 No. 22	9 Mar 2012 (see F2012L00553)	10 Mar 2012	—
2012 No. 23	9 Mar 2012 (see F2012L00554)	10 Mar 2012	—
2012 No. 24	9 Mar 2012 (see F2012L00555)	10 Mar 2012	—
2012 No. 25	9 Mar 2012 (see F2012L00556)	10 Mar 2012	—
2012 No. 40	5 Apr 2012 (see F2012L00796)	9 Apr 2012	—
2012 No. 59	11 May 2012 (see F2012L01016)	12 May 2012	—
2012 No. 191	17 Aug 2012 (see F2012L01693)	18 Aug 2012	—
2012 No. 192	17 Aug 2012 (see F2012L01694)	18 Aug 2012	—
2012 No. 193	17 Aug 2012 (see F2012L01695)	18 Aug 2012	—
2012 No. 194	17 Aug 2012 (see F2012L01696)	18 Aug 2012	—
2012 No. 195	17 Aug 2012 (see F2012L01697)	18 Aug 2012	—
66, 2013	23 May 2013 (see F2013L00825)	28 May 2013 (see s.2)	—
160, 2013	11 July 2013 (see F2013L01353)	12 July 2013	—
161, 2013	11 July 2013 (see F2013L01357)	12 July 2013	—
162, 2013	11 July 2013 (see F2013L01358)	12 July 2013	—
163, 2013	11 July 2013 (see F2013L01354)	12 July 2013	—
164, 2013	11 July 2013 (see F2013L01356)	12 July 2013	—
165, 2013	11 July 2013 (see F2013L01355)	12 July 2013	—

(a) Schedule 1 (item 3) of the Criminal Code Amendment (Terrorist Organisations) Act 2002 provides as follows:

3 Effect of regulations made before commencement of this Act

In spite of anything in subsection 102.1(4) of the Criminal Code before it was repealed, or in the regulations concerned, regulations made for the purposes of paragraph (c) of the definition of terrorist organisation in section 102.1 of the Criminal Code that were notified in the Gazette before the commencement of this Act are deemed to have taken effect on 21 October 2002. Section 48 of the Acts Interpretation Act 1901 has effect subject to this item.

(b) The repeal by the Criminal Code (Repeal of Amendments) Regulations 2009 (SLI 2009 No. 176) of the Criminal Code Amendment Regulations 2009 (No. 8) (SLI 2009 No. 124), the Criminal Code Amendment Regulations 2009 (No. 9) (SLI 2009 No. 125), the Criminal Code Amendment Regulations 2009 (No. 10) (SLI 2009 No. 126) and the Criminal Code Amendment Regulations 2009 (No. 11) (SLI 2009 No. 127) takes effect before these instruments commenced, the amendments made by the instruments are taken never to have come into effect.

These Regulations commence on the first day on which they are no longer liable to be disallowed, or to have been taken to have been disallowed, under section 42 of the Legislative Instruments Act 2003.

Note: The disallowance period provided for by section 42 of the Legislative Instruments Act 2003 may be extended if a report on a review of these Regulations by the Parliamentary Joint Committee on ASIO, ASIS and DSD is tabled within 15 sittings days after the Regulations are tabled—see subsection 102.1A(3) of the Criminal Code Act 1995.

The Criminal Code Amendment Regulations 2010 (No. 4) (SLI 2010 No. 222) commenced on 27 November 2010.

Endnote 2—Amendment history

This endnote sets out the amendment history of the Criminal Code Regulations 2002.

ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted exp. = expired or ceased to have effect
Provision affected	How affected
Part 1
Heading to Part 1...........	ad. 2002 No. 248
r. 3.....................	am. 2007 No. 265
Part 2
Part 2...................	ad. 2002 No. 248
Heading to r. 4.............	rep. 2005 No. 298
r. 4.....................	ad. 2002 No. 248
	rs. 2003 No. 184
	am. 2003 No. 285; 2005 Nos. 85, 86, 87 and 88
	rep. 2005 No. 298
	ad. 2006 No. 178
	am. 2006 No. 280
Note to r. 4...............	am. 2003 No. 285
	rep. 2005 No. 298
r. 4A....................	ad. 2004 No. 283
	rs. 2006 No. 220, 2008 No. 160; 2010 No. 219
	rep. No. 161, 2013
r. 4B....................	ad. 2004 No. 284
	rs. 2006 No. 221; 2008 No. 161; 2010 No. 220
	rep. No. 165, 2013
r. 4C....................	ad. 2004 No. 311
	rs. 2006 No. 276; 2008 No. 218; 2010 No. 253
	rep. No. 160, 2013
r. 4D....................	ad. 2004 No. 312
	rs. 2006 No. 277; 2008 No. 220; 2010 No. 252
	rep. No. 164, 2013
r. 4E....................	ad. 2004 No. 313
	rs. 2006 No. 278
	rep. 2012 No. 191
r. 4F....................	ad. 2004 No. 314
	rs. 2006 No. 279; 2008 No. 162; 2010 No. 221
	rep. No. 163, 2013
r. 4G....................	ad. 2005 No. 23
	rs. 2007 No. 3; 2008 No. 219; 2010 No. 254
	rep. No. 162, 2013
r. 4H....................	ad. 2005 No. 36
	rs. 2007 No. 39; 2009 No. 34; 2012 No. 22
r. 4I....................	ad. 2005 No. 60
	rs. 2007 No. 47; 2009 No. 35
	rep. 2012 No. 191
r. 4J....................	ad. 2005 No. 58
	rs. 2007 No. 48; 2009 No. 39; 2012 No. 23
r. 4K....................	ad. 2005 No. 57
	rs. 2007 No. 52; 2009 No. 36; 2012 No. 24
r. 4L....................	ad. 2005 No. 61
	rs. 2007 No. 49; 2009 No. 38; 2012 No. 25
r. 4M...................	ad. 2005 No. 59
	rs. 2007 No. 50
	rep. 2012 No. 191
r. 4N....................	ad. 2005 No. 62
	rs. 2007 No. 51; 2009 No. 37
	rep. 2012 No. 191
r. 4P....................	ad. 2005 No. 88
	rep. 2005 No. 214
r. 4Q....................	ad. 2005 No. 85
	rs. 2007 No. 125; 2009 No. 77; 2012 No. 59
r. 4R....................	ad. 2005 No. 86
	rep. 2005 No. 214
r. 4S....................	ad. 2005 No. 87
	rep. 2005 No. 214
r. 4T....................	ad. 2005 No. 214
	rs. 2007 No. 265; 2009 No. 212; 2012 No. 194
r. 4U....................	ad. 2005 No. 214
	rs. 2007 No. 266; 2009 No. 213; 2012 No. 191
r. 4V....................	ad. 2005 No. 214
	rs. 2007 No. 267; 2009 No. 214; 2012 No. 192
r. 4W...................	ad. 2005 No. 298
	rs. 2007 No. 290; 2009 No. 215; 2012 No. 195
r. 4X....................	ad. 2009 No. 208
	rs. 2012 No. 193
r. 4Y....................	ad. 2010 No. 222
Part 3
Heading to Part 3...........	rs. No. 66, 2013
Division 3.1
Heading to Div. 3.1 of Part 3	ad. No. 66, 2013
Part 3...................	ad. 2003 No. 30
r. 5AA..................	ad. 2011 No. 45
	rep. 2012 No. 40
r. 5AB...................	ad. 2011 No. 45
	rep. 2012 No. 40
r. 5AC...................	ad. 2011 No. 45
	rep. 2012 No. 40
r. 5.....................	ad. 2003 No. 30
Division 3.2
Div. 3.2 of Part 3............	ad. No. 66, 2013
r. 5A....................	ad. No. 66, 2013
r. 5B....................	ad. No. 66, 2013
r. 5C....................	ad. No. 66, 2013
r. 5D....................	ad. No. 66, 2013
r. 5E....................	ad. No. 66, 2013
r. 5F....................	ad. No. 66, 2013
Part 4
Heading to Part 3...........	ad. 2002 No. 248
Renumbered as Part 4........	2003 No. 30
r. 4
Renumbered as r. 5..........	2002 No. 248
r. 5
Renumbered as r. 6..........	2003 No. 30
Schedule 1
Schedule 1................	ad. 2002 No. 248
	am. 2002 Nos. 249, 250, 269, 270, 271 and 272; 2003 Nos. 43, 59, 60, 61, 62, 63 and 64; 2004 Nos. 83, 283, 284, 311, 312, 313 and 314; 2005 Nos. 36, 57, 58, 59, 60, 61 and 62
	rep. 2005 No. 88
	ad. 2006 No. 178
	am. 2006 No. 280
Heading to Schedule 1A.......	rs. 2003 No. 285
	rep. 2005 No. 298
	ad. 2011 No. 45
	rep. 2012 No. 40
Schedule 1A..............	ad. 2003 No. 184
	rep. 2005 No. 298
	ad. 2011 No. 45
	rep. 2012 No. 40
Heading to Part 1...........	ad. 2003 No. 285
	rep. 2005 No. 85
	ad. 2011 No. 45
	rep. 2012 No. 40
Part 1...................	rep. 2005 No. 85
	ad. 2011 No. 45
	rep. 2012 No. 40
Part 2...................	ad. 2003 No. 285
	rep. 2005 No. 86
	ad. 2011 No. 45
	rep. 2012 No. 40
Part 3...................	ad. 2003 No. 285
	rep. 2005 No. 87
	ad. 2011 No. 45
	rep. 2012 No. 40
Part 4...................	ad. 2011 No. 45
	rep. 2012 No. 40
Schedule 2
Schedule 2................	ad. 2003 No. 30
Schedule 3
Schedule 3................	ad. No. 66, 2013
Schedule 4
Schedule 4................	ad. No. 66, 2013

Endnote 3—Uncommenced amendments [none]

There are no uncommenced amendments.

Endnote 4—Misdescribed amendments [none]

There are no misdescribed amendments.